Фиброзирующий альвеолит как дебютполимиозита с тяжелым антисинтетазнымсиндромом
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Список литературы
1. Антелава О.А., Соловьев С.К,. Хитров А.Н, Насонов Е.Л. Новые аспекты фармакотерапии идиопатических воспалительных миопатий (Обзор литературы). Рус. мед. журн. 2006; 14 (8): 260, 627–9.
2. Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. Поражение легких при полимиозите и дерматомиозите. Интерстициальные заболевания легких. Руководство для врачей. Под ред. М.М. Ильковича, А.Н. Кокосова. СПб.: Нордмедиздат, 2005: 274–87.
3. Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. и др. Поражение легких при полимиозите и дерматомиозите. Клин. мед. 1998; 2: 20–4.
4. Насонов Е.Л., Штутман В.З., Саложин К.В. и др. Клинико-иммунологическая гетерогенность идиопатических воспалительных миопатий. Клин. мед. 1995; 2: 4–8.
5. Идиопатические воспалительные миопатии. Клинические рекомендации. Ревматология. М., 2005: 192–201.
6. Овчаренко С.И., Петухова Н.В., Слукина О.Г. Поражение легких по типу интерстициальной болезни у больной с дерматомиозитом. Новые Санкт-Петербургские врачебные ведомости. 2001; 2: 49–51.
7. Adansson JY. Radiation enhaces silica translocation to the pulmonary interstitium and increases fibrosis in mice. Environ Health Perspekt. 1992; 97: 233–8.
8. Asanuma Y, Yamada H, Matsuda T et al. Successful treatment of interstitial pneumonia with lipo-PGE1 and pentoxilylline in a patient with dermatomyositis. Ryumachi 1997; 37 (5): 719–26.
9. Bach GL, Stock K-P. Polymyositis/Dermatomyositis: Klinik, Aetiopathogenese und moegliche ausloesende Faktoren. Artritis + Rheuma 1992; 12 (1): 20–4.
10. Betteridge Z, Gunawardena H, North J et al. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) assotiated with polymyositis and interstitial pneumonia. Rheumatol 2007; 46: 1005–8.
11. Blechynden LM, Lawson MA, Tabarias H et al. Myositis induced by naked DNA immunization with the gene for hystidyl-tRNA. Hum Gene Ther 1997; 8 (12): 1469–80.
12. Duncan PE, Criffin JP, Garcia A. Fibrosing alveolitis in polymyositis: a review of histologically cases. Am J Med 1974; 57: 621–6.
13. Fathi М, Vikgren J, Boijsen M et al. Interstitial lung disease in Polymyositis and Dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arth Rheu (Arth Care Res) 2008; 59 (5): 677–85.
14. Hashish L, Trieu EP, Sadanandan P, Targoff IN. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (absract). Arth Rheum 2005; 52 (Suppl. 9): 312.
15. Hirakata H, Suwa A, Takeda Y et al. Electronic cell conting to measure total cell numbers in bronchoalveolarlavage fluid. Eur Respir J 1994; 7: 1527–31.
16. Yoshifuji H, Fujii T, Kobayashi S et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006; 39: 233–41.
17. Ishikawa S, Takei Y, Maruyama T, Koyama S, Hanyu N. A case of polymyositis presenting pregnancy with acute respiratory failure. Rinsho-Shinkeigaku 2000; 40 (2): 140–4.
18. Mаrir IE, Hachulla P, Erin S. Interstitial Lung Disease in Polymyositis and Dermatomyositis Arthritis & Rheumatism (Arth Res) 2002; 47 (6): 614–22.
19. Mills ES, Matheus WH. Interstitial pneumonitis in dermatomyositis. JAMA 1956; 160: 1467–70.
20. Nishikai M, Ohya K, Kosaka M et al. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. Br J Rheumatol 1998; 37 (4): 357–61.
21. O'Leary PA, Waisman M. Dermatomyositis: A stady of forty cases. Arch.Dermatol.Syph 1940; 41: 1001–19.
22. Philips T, Leigh I, Wright J. Dermatomyositis and pulmonary fibrosis associated with anti-Jo-1 antibody. J of the Am Acad Dermatol 1988; 5: 381–2.
23. Rowen AJ, Reiched J. Dermatomyositiswith lung involvement treated with azathioprine. Resperation 1983; 44: 143–6.
24. Salaffi F, Carotti M, Baldelli S et al. Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings. Radiol Med Torino 1999; 97 (1–2): 33–41.
2. Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. Поражение легких при полимиозите и дерматомиозите. Интерстициальные заболевания легких. Руководство для врачей. Под ред. М.М. Ильковича, А.Н. Кокосова. СПб.: Нордмедиздат, 2005: 274–87.
3. Бондаренко И.Б., Мухин Н.А., Насонов Е.Л. и др. Поражение легких при полимиозите и дерматомиозите. Клин. мед. 1998; 2: 20–4.
4. Насонов Е.Л., Штутман В.З., Саложин К.В. и др. Клинико-иммунологическая гетерогенность идиопатических воспалительных миопатий. Клин. мед. 1995; 2: 4–8.
5. Идиопатические воспалительные миопатии. Клинические рекомендации. Ревматология. М., 2005: 192–201.
6. Овчаренко С.И., Петухова Н.В., Слукина О.Г. Поражение легких по типу интерстициальной болезни у больной с дерматомиозитом. Новые Санкт-Петербургские врачебные ведомости. 2001; 2: 49–51.
7. Adansson JY. Radiation enhaces silica translocation to the pulmonary interstitium and increases fibrosis in mice. Environ Health Perspekt. 1992; 97: 233–8.
8. Asanuma Y, Yamada H, Matsuda T et al. Successful treatment of interstitial pneumonia with lipo-PGE1 and pentoxilylline in a patient with dermatomyositis. Ryumachi 1997; 37 (5): 719–26.
9. Bach GL, Stock K-P. Polymyositis/Dermatomyositis: Klinik, Aetiopathogenese und moegliche ausloesende Faktoren. Artritis + Rheuma 1992; 12 (1): 20–4.
10. Betteridge Z, Gunawardena H, North J et al. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) assotiated with polymyositis and interstitial pneumonia. Rheumatol 2007; 46: 1005–8.
11. Blechynden LM, Lawson MA, Tabarias H et al. Myositis induced by naked DNA immunization with the gene for hystidyl-tRNA. Hum Gene Ther 1997; 8 (12): 1469–80.
12. Duncan PE, Criffin JP, Garcia A. Fibrosing alveolitis in polymyositis: a review of histologically cases. Am J Med 1974; 57: 621–6.
13. Fathi М, Vikgren J, Boijsen M et al. Interstitial lung disease in Polymyositis and Dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arth Rheu (Arth Care Res) 2008; 59 (5): 677–85.
14. Hashish L, Trieu EP, Sadanandan P, Targoff IN. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome (absract). Arth Rheum 2005; 52 (Suppl. 9): 312.
15. Hirakata H, Suwa A, Takeda Y et al. Electronic cell conting to measure total cell numbers in bronchoalveolarlavage fluid. Eur Respir J 1994; 7: 1527–31.
16. Yoshifuji H, Fujii T, Kobayashi S et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006; 39: 233–41.
17. Ishikawa S, Takei Y, Maruyama T, Koyama S, Hanyu N. A case of polymyositis presenting pregnancy with acute respiratory failure. Rinsho-Shinkeigaku 2000; 40 (2): 140–4.
18. Mаrir IE, Hachulla P, Erin S. Interstitial Lung Disease in Polymyositis and Dermatomyositis Arthritis & Rheumatism (Arth Res) 2002; 47 (6): 614–22.
19. Mills ES, Matheus WH. Interstitial pneumonitis in dermatomyositis. JAMA 1956; 160: 1467–70.
20. Nishikai M, Ohya K, Kosaka M et al. Anti-Jo-1 antibodies in polymyositis or dermatomyositis: evaluation by ELISA using recombinant fusion protein Jo-1 as antigen. Br J Rheumatol 1998; 37 (4): 357–61.
21. O'Leary PA, Waisman M. Dermatomyositis: A stady of forty cases. Arch.Dermatol.Syph 1940; 41: 1001–19.
22. Philips T, Leigh I, Wright J. Dermatomyositis and pulmonary fibrosis associated with anti-Jo-1 antibody. J of the Am Acad Dermatol 1988; 5: 381–2.
23. Rowen AJ, Reiched J. Dermatomyositiswith lung involvement treated with azathioprine. Resperation 1983; 44: 143–6.
24. Salaffi F, Carotti M, Baldelli S et al. Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings. Radiol Med Torino 1999; 97 (1–2): 33–41.
Авторы
И.Б.Бондаренко, О.А.Антелава, Е.Л.Насонов
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.